| Wissenschaftl. Titel | Early treatment intensification in patients with high risk Mantle Cell Lymphoma using CAR-T-cell treatment after an abbreviated induction therapy with Rituximab and Ibrutinib and 6 months Ibrutinib maintenance (Arm A) as compared to standard of care induction and maintenance (Arm B) |
| Erkrankung |
Blut:
Non-Hodgkin-Lymphome (NHL), niedrig-maligne:
weitere
Blut: Non-Hodgkin-Lymphome (NHL), hoch-maligne: weitere |
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 07.11.2024 Admin04
geändert 18.11.2024 Admin02